BC21 (NSC 109268) is a beta-catenin/Tcf4 inhibitor with an IC50 of 5 µM. BC21 effectively inhibits the binding of beta-catenin to Tcf4-derived peptides and suppresses beta-catenin/Tcf4-driven reporter gene activity. BC21 can be utilized in cancer research[1].
Molecular Weight:
678.64
CAS Number:
[691005-38-6]
Formula:
C32H36Cl2Cu2N2O2
Target:
beta-catenin
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted